| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Eledon Pharmaceuticals, Inc. | President, Director | Stock Option (right to buy) | 243,000 | 10 Jan 2025 | Direct | ||
| Eledon Pharmaceuticals, Inc. | President, Director | Restricted Stock Units | 27,000 | 10 Jan 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ELDN | Eledon Pharmaceuticals, Inc. | 10 Jan 2025 | 2 | $0 | 4 | President, Director | 13 Jan 2025, 17:30 |
| ELDN | Eledon Pharmaceuticals, Inc. | 21 Nov 2024 | 1 | $0 | 4 | President, Director | 22 Nov 2024, 17:00 |
| ELDN | Eledon Pharmaceuticals, Inc. | 13 Jun 2024 | 1 | $0 | 4 | President, Director | 14 Jun 2024, 17:00 |
| ELDN | Eledon Pharmaceuticals, Inc. | 01 May 2023 | 1 | $0 | 4 | President, Director | 02 May 2023, 18:50 |
| ELDN | Eledon Pharmaceuticals, Inc. | 01 Feb 2023 | 1 | $0 | 4 | President, Director | 02 Feb 2023, 17:11 |
| ELDN | Eledon Pharmaceuticals, Inc. | 23 Nov 2022 | 1 | +$2,597 | 4 | President, Director | 23 Nov 2022, 15:05 |
| ELDN | Eledon Pharmaceuticals, Inc. | 01 Feb 2022 | 1 | $0 | 4 | President, Director | 02 Feb 2022, 16:37 |